SCHEMBL2522380

SCHEMBL2522380

CCCCCSCC(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
MAPT P10636 4/20 0.55
GMNN O75496 1/20 0.55
TP53 P04637 1/20 0.55
POLB P06746 1/20 0.55
THRB P10828 1/20 0.55
CYP2C9 P11712 1/20 0.55
BLM P54132 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CES2 O00748 6/20 0.50
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6465332 0.98 MAPT (0.58) ALDH1A1MAPTGMNNTP53POLB
SCHEMBL14998165 0.98 MAPT (0.58) ALDH1A1MAPTGMNNTP53POLB
SCHEMBL28437029 0.98 MAPT (0.58) ALDH1A1MAPTGMNNTP53POLB
SCHEMBL15457916 0.98 MAPT (0.58) ALDH1A1MAPTGMNNTP53POLB
SCHEMBL8756244 0.95 ALDH1A1 (0.59) ALDH1A1MAPTGMNNTP53POLB
SCHEMBL18737489 0.91 SMN1; SMN2 (0.57) ALDH1A1MAPTGMNNTP53POLB
SCHEMBL9622162 0.87 MAPT (0.53) ALDH1A1MAPTGMNNTP53POLB
SCHEMBL18737683 0.85 HDAC3 (0.50) ALDH1A1MAPTGMNNTP53POLB
SCHEMBL17399693 0.83 HSD17B3 (0.63) MAPTGMNNTP53POLBTHRB
SCHEMBL3357504 0.83 L3MBTL1 (0.55) MAPTGMNNTP53POLBTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7385087-B2 Method for producing a-(3-arylthio)-acetophenones BASF AKTIENGESELLSCHAFT (DE) 2008-06-10 US claimed
CN-100345824-C Preparation method of alpha- (3-arylthio) acetophenone BASF AG (DE) 2007-10-31 CN claimed
EP-1678127-B1 METHOD FOR THE PRODUCTION OF ALPHA-(3-ARYLTHIO)-ACETOPHENONES BASF AG (DE) 2007-07-25 EP claimed
US-20070060776-A1 Method for the production of alpha-(3-arylthio)-acetophenones BASF AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
EP-1603868-B1 METHOD FOR PRODUCING ALPHA-(3-ARYLTHIO)-ACETOPHENONES BASF AG (DE) 2006-09-13 EP claimed
US-20060178537-A1 Method for producing a-(3-arylthio)-acetophenones BASF AKTIENGESELLSCHAFT (DE) 2006-08-10 US claimed
EP-1678127-A1 METHOD FOR THE PRODUCTION OF ALPHA-(3-ARYLTHIO)-ACETOPHENONES BASF AKTIENGESELLSCHAFT (DE) 2006-07-12 EP claimed
CN-1756738-A Method for producing a-(3-arylthio)-acetophenones BASF AG (DE) 2006-04-05 CN claimed
EP-1603868-A1 METHOD FOR PRODUCING a-(3-ARYLTHIO)-ACETOPHENONES BASF AKTIENGESELLSCHAFT (DE) 2005-12-14 EP claimed
WO-2005042477-A1 METHOD FOR THE PRODUCTION OF $G(A)-(3-ARYLTHIO)-ACETOPHENONES BASF AKTIENGESELLSCHAFT (DE) 2005-05-12 WO claimed
WO-2004078705-A1 METHOD FOR PRODUCING α-(3-ARYLTHIO)-ACETOPHENONES BASF AKTIENGESELLSCHAFT (DE) 2004-09-16 WO claimed
US-20230013624-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-01-19 US disclosed
US-9790199-B1 Sulfoxide compound and method of producing benzothiophene derivatives using the same NATIONAL SUN YAT-SEN UNIVERSITY (TW) 2017-10-17 US disclosed
US-9766547-B2 Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method of manufacturing electronic device using the same, and electronic device FUJIFILM CORPORATION (JP) 2017-09-19 US disclosed
US-9751852-B1 Sulfoxide compound and method of producing benzothiophene derivatives using the same NATIONAL SUN YAT-SEN UNIVERSITY (TW) 2017-09-05 US disclosed
WO-1997034888-A1 SYNTHESIS OF 3-[4-(2-AMINOETHOXY)-BENZOYL]-2-ARYL-6-HYDROXY-BENZO[b]THIOPHENES ELI LILLY AND COMPANY (US) 1997-09-25 WO disclosed
US-5629425-A NONSTEROIDAL ANTIESTROGEN ELI LILLY AND COMPANY (US) 1997-05-13 US disclosed
WO-1997004361-A1 HETEROGENEOUS PHOTO-INITIATORS, PHOTOPOLYMERISABLE COMPOSITIONS AND THEIR USE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1997-02-06 WO disclosed
US-4185110-A ANTIALLERGENS CIBA-GEIGY CORPORATION (US) 1980-01-22 US disclosed
US-4055652-A 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof SYNTEX (U.S.A.) INC. (US) 1977-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060776-A1 Method for the production of alpha-(3-arylthio)-acetophenones CBR3, CYB5R3, ME3 ALDH1A1 764/4885MAPT 4368/4885GMNN 3147/4885
US-20060178537-A1 Method for producing a-(3-arylthio)-acetophenones ARSA, TST, SULT1A1 ALDH1A1 74/4885MAPT 4195/4885GMNN 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.